A Clinical Evaluation of Wearing Surface in Total Hip Replacement

This study has been completed.
Sponsor:
Information provided by:
Frederiksberg University Hospital
ClinicalTrials.gov Identifier:
NCT00289692
First received: February 9, 2006
Last updated: November 26, 2007
Last verified: November 2007
  Purpose

Hip prosthesis will be evaluated at wearing and cytokines.


Condition Intervention Phase
THR
Device: Total Hip Replacement
Phase 4

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Open Label

Resource links provided by NLM:


Further study details as provided by Frederiksberg University Hospital:

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • THR
  • Informed concent

Exclusion Criteria:

  • Osteoporosis
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00289692

Sponsors and Collaborators
Frederiksberg University Hospital
Investigators
Principal Investigator: arne borgwardt, md Frederiksberg University Hospital
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00289692     History of Changes
Other Study ID Numbers: KF 01-355/98
Study First Received: February 9, 2006
Last Updated: November 26, 2007
Health Authority: Denmark: Ethics Committee

ClinicalTrials.gov processed this record on July 29, 2014